OLYMPUS | Newshttps://www.olympus-global.com/NewsenOlympus CorporationThu, 9 Apr 2026 11:00:00 +0900Update: IR Library "Olympus Business"https://www.olympus-global.com/ir/data/medical.htmlThu, 9 Apr 2026 11:00:00 +0900Notification for the Candidates for the Board of Directorshttps://www.olympus-global.com/ir/data/announcement/2026.htmlFri, 27 Mar 2026 15:40:00 +0900Sharing the Importance of Screening Through the Experience of a Colorectal Cancer Survivor — A “True to Life” Storyhttps://www.olympus-global.com/news/2026/an02977.htmlMon, 2 Mar 2026 11:00:00 +0900I Feel Like I Got a Second Chance": An Engineer’s Journey with Bronchial Valves — A “True to Life” Storyhttps://www.olympus-global.com/news/2026/an02974.htmlWed, 25 Feb 2026 11:00:00 +0900Third Quarter Financial Results for Fiscal Year 2026https://www.olympus-global.com/ir/data/brief/2026.html?page=irFri, 13 Feb 2026 15:30:00 +0900Notice Concerning the Revision of Financial Forecasthttps://www.olympus-global.com/ir/data/announcement/2026.htmlFri, 13 Feb 2026 15:29:00 +0900Notice Concerning Change of Executive Officerhttps://www.olympus-global.com/ir/data/announcement/2026.htmlFri, 13 Feb 2026 15:28:00 +0900EAGLE Trial Shows Olympus® CADDIE™ AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesionshttps://www.olympus-global.com/news/2026/nr02963.htmlTue, 3 Feb 2026 10:00:00 +0900Notice Concerning Change of Executive Officershttps://www.olympus-global.com/ir/data/announcement/2026.htmlWed, 28 Jan 2026 15:40:00 +0900Olympus to Present at J.P. Morgan Healthcare Conferencehttps://www.olympus-global.com/news/2026/an02958.htmlMon, 5 Jan 2026 09:00:00 +0900An employee’s recovery from an esophageal disease through minimally invasive surgery — A “True to Life” Storyhttps://www.olympus-global.com/news/2025/an02951.htmlMon, 15 Dec 2025 11:00:00 +0900Notice Regarding Additional Investment in Corporate Venture Capital Fund “Olympus Innovation Ventures Fund II”https://www.olympus-global.com/ir/data/announcement/2025.htmlMon, 15 Dec 2025 08:40:00 +0900Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership https://www.olympus-global.com/news/2025/nr02953.htmlMon, 15 Dec 2025 08:30:00 +0900Second Quarter Financial Results for Fiscal Year 2026https://www.olympus-global.com/ir/data/brief/2026.html?page=irFri, 7 Nov 2025 15:34:00 +0900Notice Regarding the Formulation of the Corporate Strategyhttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 7 Nov 2025 15:33:00 +0900Notice: Concerning Change of Representative Executive Officer and Executive Officerhttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 7 Nov 2025 15:32:00 +0900Notice Regarding Global Personnel Optimizationhttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 7 Nov 2025 15:31:00 +0900Olympus Unveils Corporate Strategyhttps://www.olympus-global.com/news/2025/nr02932.htmlFri, 7 Nov 2025 15:30:00 +0900Notice Regarding Completion of Share Repurchase and Cancellation of Treasury Shareshttps://www.olympus-global.com/ir/data/announcement/2025.htmlTue, 4 Nov 2025 17:10:00 +0900Olympus Introduces a NBI+TXI™ Observation Mode to the EVIS X1™ Endoscopy System CV-1500 Video System Centerhttps://www.olympus-global.com/news/2025/nr02923.htmlWed, 29 Oct 2025 11:00:00 +0900Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealinghttps://www.olympus-global.com/news/2025/nr02919.htmlTue, 21 Oct 2025 23:00:00 +0900Olympus: Feasibility Study on Endoscopy Infection Control Systems in India Selected for METI’s “Global South Co-Creation Subsidy Program”https://www.olympus-global.com/news/2025/nr02917.htmlTue, 21 Oct 2025 11:00:00 +0900A new “True to Life Story” featuring the fight with cancer of former WBA champion Shinji Takeharahttps://www.olympus-global.com/news/2025/an02916.htmlTue, 14 Oct 2025 11:00:00 +0900Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Devicehttps://www.olympus-global.com/news/2025/nr02913.htmlMon, 6 Oct 2025 15:00:00 +0900Published Integrated Report 2025https://www.olympus-global.com/ir/data/integratedreport/2025.htmlFri, 3 Oct 2025 14:00:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2025.htmlWed, 1 Oct 2025 17:10:00 +0900Olympus Launches OLYSENSE CAD/AI in the US and Europe https://www.olympus-global.com/news/2025/nr02907.htmlTue, 30 Sep 2025 22:00:00 +0900Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont™ Tyvek® with Renewable Attributionhttps://www.olympus-global.com/news/2025/nr02905.htmlTue, 30 Sep 2025 13:00:00 +0900Notice Concerning Judgment of Shareholder’s Derivative Lawsuithttps://www.olympus-global.com/ir/data/announcement/2025.htmlThu, 25 Sep 2025 18:20:00 +0900Olympus Announces Distribution Partnership with MacroLux Medical for Single-Use Urology Productshttps://www.olympus-global.com/news/2025/nr02897.htmlThu, 4 Sep 2025 23:15:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2025.htmlMon, 1 Sep 2025 17:10:00 +0900Olympus Launches Latest EBUS Bronchoscope BF-UCP190F in EMEA and APAChttps://www.olympus-global.com/news/2025/nr02891.htmlMon, 1 Sep 2025 17:00:00 +0900Olympus Obtains its First Medical Device Registration Certificate for a Locally-Manufactured Product in China with its Most Advanced Imaging Endoscopehttps://www.olympus-global.com/news/2025/nr02895.htmlMon, 1 Sep 2025 15:00:00 +0900First Quarter Financial Results for Fiscal Year 2026https://www.olympus-global.com/ir/data/brief/2026.html?page=irFri, 8 Aug 2025 15:30:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 1 Aug 2025 17:10:00 +0900Notification for the Agreement to Invest in Joint Venture with Revival Healthcare Capitalhttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 25 Jul 2025 16:10:00 +0900Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics https://www.olympus-global.com/news/2025/nr02877.htmlFri, 25 Jul 2025 16:00:00 +0900Supporting the Future of Vietnam’s Healthcare by Training Endoscopistshttps://www.olympus-global.com/news/2025/nr02858.htmlThu, 3 Jul 2025 13:00:00 +0900Olympus Achieves 100% Renewable Energy at Manufacturing Site in Vietnam https://www.olympus-global.com/news/2025/nr02864.htmlTue, 1 Jul 2025 13:00:00 +0900Financial Results for Fiscal Year 2025https://www.olympus-global.com/ir/data/brief/2025.html?page=irTue, 13 May 2025 15:31:00 +0900Notice Regarding Share Repurchase and Cancellation of Treasury Shareshttps://www.olympus-global.com/ir/data/announcement/2025.htmlTue, 13 May 2025 15:30:00 +0900New "True to Life Story" Featuring a Rectal Cancer Survivor is Now Livehttps://www.olympus-global.com/news/2025/nr02844.htmlFri, 9 May 2025 15:00:00 +0900Olympus Achieves Record Participation in Annual “Dress in Blue” Colorectal Cancer Awareness Month Campaignhttps://www.olympus-global.com/news/2025/nr02841.htmlWed, 7 May 2025 15:00:00 +0900Notification for the Appointment of the new Representative Executive Officer and Change of the role of the Representative Executive Officer, and Addition of Candidate for the Board of Directorshttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 25 Apr 2025 15:40:00 +0900Olympus Appoints New CEO https://www.olympus-global.com/news/2025/nr02839.htmlFri, 25 Apr 2025 15:30:00 +0900A Decade of Olympus India's Commitment to Community Welfare https://www.olympus-global.com/news/2025/nr02834.htmlTue, 22 Apr 2025 13:00:00 +0900Notification for the Candidates for the Board of Directorshttps://www.olympus-global.com/ir/data/announcement/2025.htmlThu, 27 Mar 2025 15:40:00 +0900Olympus Certified as a 2025 Sports Yell Company by the Japan Sports Agencyhttps://www.olympus-global.com/news/2025/nr02817.htmlFri, 14 Mar 2025 11:00:00 +0900Olympus Certified as a 2025 White 500 Company for Outstanding Health and Productivity Managementhttps://www.olympus-global.com/news/2025/nr02814.htmlMon, 10 Mar 2025 15:30:00 +0900Olympus Sagamihara Distribution Center Commences Operation of Automated Packaging System https://www.olympus-global.com/news/2025/nr02812.htmlWed, 5 Mar 2025 17:00:00 +0900Olympus Announces Milestone for iTind™ Device with Expanded Availability Across Major APAC Marketshttps://www.olympus-global.com/news/2025/nr02810.htmlWed, 26 Feb 2025 11:00:00 +0900Notice Concerning Change in Specified Subsidiaryhttps://www.olympus-global.com/ir/data/announcement/2025.htmlWed, 19 Feb 2025 17:10:00 +0900Third Quarter Financial Results for Fiscal Year 2025https://www.olympus-global.com/ir/data/brief/2025.htmlFri, 14 Feb 2025 15:31:00 +0900Notice: Concerning Change of the role of Representative Executive Officerhttps://www.olympus-global.com/ir/data/announcement/2025.htmlFri, 14 Feb 2025 15:31:00 +0900Olympus Recognized on CDP’s “A List”, the Highest Rating in the Field of Climate Changehttps://www.olympus-global.com/news/2025/nr02800.htmlMon, 10 Feb 2025 11:00:00 +0900Olympus Acquires Distribution Business in Chilehttps://www.olympus-global.com/news/2025/nr02794.htmlWed, 15 Jan 2025 09:00:00 +0900Notice Concerning Appeal of Shareholder’s Derivative Lawsuithttps://www.olympus-global.com/ir/data/announcement/2025.htmlMon, 6 Jan 2025 12:10:00 +0900Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Yearhttps://www.olympus-global.com/news/2024/nr02783.htmlTue, 24 Dec 2024 11:00:00 +0900Notice: Concerning Change of Executive Officerhttps://www.olympus-global.com/ir/data/announcement/2024.htmlFri, 20 Dec 2024 15:40:00 +0900Olympus Announces CEO Succession Processhttps://www.olympus-global.com/news/2024/nr02788.htmlFri, 20 Dec 2024 14:00:00 +0900Notice Concerning Judgement of Shareholder’s Derivative Lawsuithttps://www.olympus-global.com/ir/data/announcement/2024.htmlThu, 5 Dec 2024 17:10:00 +0900Published Integrated Report 2024https://www.olympus-global.com/ir/data/integratedreport/2024.htmlWed, 4 Dec 2024 11:00:00 +0900Notice Regarding Completion of Share Repurchase and Cancellation of Treasury Shareshttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 20 Nov 2024 17:10:00 +0900Demonstration Shows IOWN APN’s Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World’s First Cloud Endoscopy Systemhttps://www.olympus-global.com/news/2024/nr02772.htmlTue, 19 Nov 2024 15:30:00 +0900Second Quarter Financial Results for Fiscal Year 2025https://www.olympus-global.com/ir/data/brief/2025.htmlFri, 8 Nov 2024 15:30:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlFri, 1 Nov 2024 17:10:00 +0900Notice Regarding Change in Representative Executive Officerhttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 28 Oct 2024 08:35:00 +0900【Notice】New "True to Life Story" featuring the experience of an Olympus employee with irritable bowel syndrome and colon polyps is now livehttps://www.olympus-global.com/news/2024/nr02763.htmlMon, 21 Oct 2024 15:00:00 +0900Notice Concerning Ruling of the Lawsuit involving Consolidated Subsidiaryhttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 16 Oct 2024 15:10:00 +0900Olympus Announces CE Approval for Three Cloud-based AI Medical Devices and Announces Plans for Launch of AI-Powered Endoscopy Ecosystem in 2025https://www.olympus-global.com/news/2024/nr02759.htmlTue, 15 Oct 2024 13:00:00 +0900Olympus Partners with Rizal Medical Center - Center for Digestive and Liver Care for Digestive Health Training in the Philippines https://www.olympus-global.com/news/2024/nr02756.htmlWed, 9 Oct 2024 11:00:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlTue, 1 Oct 2024 17:10:00 +0900Olympus Launches VISERA S, a New Imaging Platformhttps://www.olympus-global.com/news/2024/nr02751.htmlMon, 30 Sep 2024 15:00:00 +0900Olympus to Begin Sales activities of Aplio i800 EUS in Europe, Japan and Oceaniahttps://www.olympus-global.com/news/2024/nr02747.htmlTue, 24 Sep 2024 15:00:00 +0900Olympus Launches New 4K Camera Head for Urological Endoscopyhttps://www.olympus-global.com/news/2024/nr02746.htmlFri, 20 Sep 2024 15:00:00 +0900First Cloud-Based AI Endoscopy System for Colonoscopy Receives FDA Clearancehttps://www.olympus-global.com/news/2024/nr02743.htmlFri, 6 Sep 2024 13:00:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 2 Sep 2024 17:10:00 +0900Olympus Launches New POWERSEAL™ Sealer/Divider 5mm Devices, Extends Advanced Bipolar Surgical Energy Portfolio https://www.olympus-global.com/news/2024/nr02724.htmlTue, 27 Aug 2024 11:00:00 +0900First Quarter Financial Results https://www.olympus-global.com/ir/data/brief/2025.htmlWed, 7 Aug 2024 15:03:00 +0900Notice Concerning Change of Executive Officershttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 7 Aug 2024 15:02:00 +0900(Progress of disclosure matters) Notice Concerning Transfer of Orthopedic Businesshttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 7 Aug 2024 15:01:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlThu, 1 Aug 2024 17:10:00 +0900Notice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systemshttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 24 Jul 2024 16:10:00 +0900【Notice】 New "True to Life Story" featuring the endoscopy experience of Japanese actor Takeshi Tsuruno is now livehttps://www.olympus-global.com/news/2024/nr02720.htmlFri, 19 Jul 2024 17:00:00 +0900(Progress of disclosure matters) Notice Concerning Transfer of Orthopedic Businesshttps://www.olympus-global.com/ir/data/announcement/2024.htmlFri, 12 Jul 2024 17:10:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 1 Jul 2024 17:10:00 +0900Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systemshttps://www.olympus-global.com/ir/data/announcement/2024.htmlWed, 26 Jun 2024 17:10:00 +0900Overview of Evaluation Results on the Effectiveness of the Board of Directors of Olympushttps://www.olympus-global.com/ir/data/announcement/2024.htmlTue, 18 Jun 2024 15:10:00 +0900Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, Indiahttps://www.olympus-global.com/news/2024/nr02701.htmlWed, 12 Jun 2024 11:00:00 +0900Notice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systems and Partial Loss of Rightshttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 10 Jun 2024 15:10:00 +0900Notice Regarding Status of Share Repurchasehttps://www.olympus-global.com/ir/data/announcement/2024.htmlTue, 4 Jun 2024 15:10:00 +0900Notice Concerning Transfer of Orthopedic Businesshttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 27 May 2024 08:40:00 +0900Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systemshttps://www.olympus-global.com/ir/data/announcement/2024.htmlMon, 13 May 2024 17:10:00 +0900Notice Regarding Share Repurchase and Cancellation of Treasury Shareshttps://www.olympus-global.com/ir/data/announcement/2024.htmlFri, 10 May 2024 15:00:00 +0900Financial Resultshttps://www.olympus-global.com/ir/data/brief/2024.htmlFri, 10 May 2024 15:00:00 +0900[Notice] Launch of new True to Life story that introduces a new initiative using digital technologies to address challenges in local gastric cancer screenings https://www.olympus-global.com/news/2024/nr02683.htmlWed, 1 May 2024 15:00:00 +0900[Notice] New True to Life story featured “C-TEC” the Endoscopy Training Center is now launched https://www.olympus-global.com/news/2024/nr02681.htmlThu, 25 Apr 2024 15:00:00 +0900[Notice] Odin Vision Leveraged NVIDIA Inception Program for Startups to Build Cloud-Connected AI Models to Support Endoscopyhttps://www.olympus-global.com/news/2024/nr02676.htmlMon, 22 Apr 2024 15:00:00 +0900[Notice] New Installment in True to Life Story Series Features Olympus Korea Corporate Social Responsibility Initiative “Going on Campaign” https://www.olympus-global.com/news/2024/nr02679.htmlFri, 19 Apr 2024 15:00:00 +0900[Notice] Launch of a New Story in the True to Life Series Featuring a Patient Diagnosed with Colorectal Cancer at 33 https://www.olympus-global.com/news/2024/nr02674.htmlFri, 12 Apr 2024 15:00:00 +0900